U.S. Food and Drug Administration Approves BOSULIF® (bosutinib) for Patients with Previously Treated Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (CML) More about Bosutinib
When will it become available in Europe?
As far as I know there is a delay that might take some time to get through EMA. Will update as soon as I have more info.
Sandy- still in Greece x
Thanks Sandy.
Enjoy your holiday.
